Layhong just deliver super EPS 7.42sen, what will EPS for much more bigger LHI ?
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3424233

Layhong just deliver super EPS 7.42sen, what will EPS for much more bigger LHI ?
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3424233

added all balance to LHI at 73sen

cut at 2.84

Penalty now in court case. It will take long time to end. All parties, have file appeal to the court independently. Gov need to spend much longer time to fight them in the court individually

In the market, Chicken and egg selling price still remain elevated, quietly making more money, increase supply to meet upcoming hari raya

When raw material cost hike - cost pass through

When raw material cost tumbling - Nothing happen to selling price in poultry feed, elevated selling still intact and maintain for extra profit margin

Actually, LHI major profit contributor is feedmill, stand to reap much higher profit margin from slumping raw material cost, soybean and corn cost price both have tumbling and downtrend spread till now 2024 for further down 15-20% if compared to Q4 2023

High cost and currency strength in Singapore have prompted visitor to swap to Msia Genting

added more at 1.03

bought GENM at 2.88

Ps check Jtiasa latest CPO production volume, down significant by 30% compared to current increase CPO 10% and further pressure on CPO price forward as competitor soybean/corn/sunflower oil are tumbling in global market .

bought uems at 1.04-1.05

Today also bought MFL at 65.5-66sen

Today also bought HLC at 4.36-4.37

today bought LHI at 68sen

today bought Teoseng at 2.22-2.25

GENS share weakness prompted portfolio to prematurely realize profit first

sold all today at 4.95-4.97

Thanks sslee

Do you know how much Rakutan analyst imply net gearing 26.6x for ? it mean Teoseng incur super huge borrowing 26.6x higher than its total equity RM 477m = RM 12.7 billion ...crazyyyyyy its brainless

In contrast, teoseng only mere have net borrowing RM 7.2m vs. annual profit RM 155m, simply record another quarter already turning Teoseng into NET CASH position

Rakutan analyst said Teoseng current net gearing of 26.6x in rather exorbitant !!!???

It must be joke.....Teoseng current borrowing is only RM 59.8m, vs. current cash holding RM 98.9m. Even take into account non current borrowing RM 46.3 term loan, total debt only RM 106.1m, stripping out cash, Teoseng only have net borrowing RM 7.2m, vs, total equity RM 477m

Supported by strong demand, the company plans to augment its egg production capacity by 4.5m eggs per day in FY24, thereby stimulating prospective earnings. Additionally, in response to evolving consumer preferences, Teo Seng is broadening its product portfolio to include downstream offerings such as boiled eggs and processed old hen products. These strategic initiatives are expected to yield enhanced and stable margins compared to its core products.

Despite temporary subsidies and price ceilings to persist until 1H24, egg prices, particularly for table eggs, are forecasted to remain elevated due to high production costs. Looking ahead to fiscal year 2024, with the removal of price ceilings and subsidies on eggs, management foresees egg prices adjusting to postsubsidy levels, approximately 48sen/egg from 43sen currently.

Therefore, we anticipate Teo Seng's financial performance to remain strong in the coming quarters, driven by higher egg production. We project Teo Seng’s FY22-25F core net profit to register a strong CAGR of 77%, underpinned by capacity and product range expansions in the layer farming segment, along with steady contributions from the animal health product distribution segment.

This stock currently trades at an attractive FY24F PE of 4.7x, which is below the 5-year forward average of 8x. Though the company's current net gearing of 26.6x in rather exorbitant, Teo Seng is poised to address this by pairing down its debts via its strong cash flow upon the upliftment of egg ceiling price and subsidy regulations by the Government in 2024. Meanwhile, Teo Seng offers an attractive dividend yield of 6%, assuming a 30% dividend payout ratio, with the board intending to distribute dividends ranging from 20%-50% of its PAT

Sslee bought Teoseng today ?

Lets breakout RM 5.00

TA chart show sign of cup and handle formation, bullish breakout is imminent next week

Last drop of capital and margin line all also fully invested in genting today.

added more genting at 4.83-4.84

Usd = RM 4.78
Sgd = RM 3.54
Pounds = RM 6.03

Sold back at 1.20

May Dragon is genting golden year, bring all prosperity, double up value.... Heng Ong Huat

Factual is GENTING continue to reap higher earning from strengthen foreign currency everyday

USD = RM 4.77
Sgd = RM 3.55
Pound = RM 6.02

bought back jtiasa at 1.13

Genting and YTLP are the only top 2 stocks derive majority earning from Singapore. In additional to SGD strength, high USD rate also beneficial at lot to Genting

https://www.thestar.com.my/business/business-news/2024/02/07/singapore-dollar-rises-to-a-fresh-record-against-ringgit

Bruce Lee exhibition in Genting. The First Tour at Times Square Stage, SkyAvenue! Kongfu Genting Go Go Go

https://www.facebook.com/photo/?fbid=789848119850321&set=pcb.789848286516971

SGD = RM 3.55 is new record breaking. But, these exchange strength only can reflect in following Q result release in May later. Be patient to entitle coming dividend first by end of these month, and await for record breaking following Q next in May 2024

Courting down time for Genting to breakout RM 4.90 and RM 5.00 very soon

SGD = RM 3.55
USD = RM 4.76
Pound = RM 6.00

Dragon328

The segmental assets & liabilities already fully reflect for each business division and countries operation.

These revenue generated business liabilities is much lower than Genting as whole group as Genting holding itself also incur borrowing for other investment purpose which is still in infancy stage, such as upstream exploration gas, investment in pre clinical and clinical pharmaceutical, vacant landbank, investment in JV and other minority stake, and any other business which have yet to generate any revenue. In addition, genting also incur borrowing o solely raise cash deposit in preparation to seize future business opportunity as reflect its interest income form half of its interest expense

Dragon328

Genting US form largest assets for Genting = RM 25.8 billion, have smallest RM 1.5 billion liabilities

Genting Sing form second largest assets for Genting = RM 18.4 billion, also only small fraction of RM 1.76 billion is liabilities

Genting Malaysia form least assets RM 12 billion, but have highest liabilities RM 2.65 billion

Moving forward, GENTING Las Vegas may surpass GENM, become second contributor to GENTING as Las Vegas operation gradually reach optimal level operation and US currency strengthen further.

Dragon328

GENTING Las Vegas currently is third largest profit contributor to GENTING, about half of GENM earning. However, if take into account effective stake, GENTING Las Vegas is almost in par if compared to GENM as it is wholly own by GENTING, whereas, GENM is 50% own by genting

Once Genting Las legas reach optimal level operation, it will seek listing in NYEX as genting US to unlock these prime assets Genting will ultimate remain as holding company, control prime casino in various country under subsidiary namey GENM, GENS and GENUS

Bear in mind, Genting Las Vegas was built at cost USD 4.3 billion at time exchnge rate was USD = RM 4.00-4.30. Now, Genting Las Vegas have begin generate profit and exchange rate is at high RM 4.76, and if such rate is sustain and Genting las Vegas may seek earlier than expected to unlock Genting las vegas through IPO in New York exchange within 1-2 year time frame

https://www.youtube.com/watch?v=Cy_D6UA45AI

Under normal circumference, FDA normally take 6 month to review clinical data before granted approval for commercialize to market. Since the submission done in July last year, it is about time for FDA to grant approval very soon now

Other assets pending to unlock is investment in Taurx pharmaceutical product which already completed clinical trial and show positive outcome. Result already submitted since last midyear to FDA for commercial approval. Another prime assets is kasuri gas which is now at development stage with first gas expect in Q2 2026

https://www.upstreamonline.com/field-development/indonesian-chinese-pairing-eye-kasuri-prize/2-1-1579909

The major earning driver for Genting now if compared to 2019 is additional profit contributor from newly open Genting Las Vegas, at cost USD 4.3 billion, which is only just started to reap profit and higher momentum growth is expected when operation gradually towrad optimal level

In 2019 prepndemic time, Genting record average EPS 12sen-16sen per quarter and its reflected share price is at RM 6.50-RM 7.30. Therefore, if genting recovery is sustainable forward consecutively record EPS > 12sen, share price should recover back to above RM 6.50 these year very soon

In 2019, the annual global societal costs of dementia were estimated at US $1313.4 billion for 55.2 million people with dementia, corresponding to US $23,796 per person with dementia. Of the total, US $213.2 billion (16%) were direct medical costs, US $448.7 billion (34%) direct social sector costs (including long-term care), and US $651.4 billion (50%) costs of informal care.

Once secure FDA approval, Commercialize taurx is expect to worth USD 15 billion. As much USD 3 billion for GENTING 20%. These translate into RM 14 billion, form 73% of GENTING current entire market cap now.

Less and less China people invest in hard assets properties, more and more opt to enjoy life like short trip oversea for sight seeing and bet in exclusive area like GENTING casino in both Msia and Sing.